Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-08-10
Original SEC Filing: Click here

---

Webplus: CPHI/20110810/10-Q_1/1/000.htm SEC Original: cphi10q063011.htm
FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer’s telephone number, including area code)

---

---

Webplus: CPHI/20110810/10-Q_1/2_EX-3.1/000.htm SEC Original: cphi10qex31063011.htm
AMENDED AND RESTATED BYLAWS OF CHINA PHARMA HOLDINGS, INC. (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of the corporation shall be established and maintained at 1209 Orange Street, Corporation Trust Center, Wilmington, New Castle County, Delaware 19801. 1.2. Principal Office. The principal office of the Corporation shall be located at the principal place of

---

---

Webplus: CPHI/20110810/10-Q_1/3_EX-31.1/000.htm SEC Original: cphi10qex311063011.htm
CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20110810/10-Q_1/4_EX-31.2/000.htm SEC Original: cphi10qex312063011.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20110810/10-Q_1/5_EX-32.1/000.htm SEC Original: cphi10qex321063011.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 ——————————– President and Chief Executive Officer EX-32.1 5 cphi10qex321063011.htm

---

---

Webplus: CPHI/20110810/10-Q_1/6_EX-32.2/000.htm SEC Original: cphi10qex322063011.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 10, 2011 ——————— (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322063011.htm

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-08-10CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216